SalesTrax.com Research: B2BSalesPros.com

Articles found below have been submitted through various PR and news sources and don’t necessary reflect the views of SalesTrax or its employees.

PR Newswire

2009-08-17 04:00
AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia

2009-08-13 16:02
TELUS Files Shelf Prospectus

2009-08-06 08:00
Bellicum Pharmaceuticals Announces Initiation of Phase I/II Clinical Trial of Novel Vaccine for Patients With Advanced Prostate Cancer

2009-08-04 20:02
Frost & Sullivan Hosts Webinar: Pay-TV Video Encoders Market and Growth Prospects

2009-08-04 12:00
Ferring Pharmaceuticals Announces Trade Name FIRMAGON(R) (degarelix for injection) for Advanced Prostate Cancer Treatment

2009-08-03 08:00
Generic Erosion of Established Agents Will Offset Growth From Uptake of Emerging Therapies in the Market for Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms

2009-07-31 20:00
Minera Andes files preliminary short form prospectus for previously announced Cdn$20 million equity financing

2009-07-29 16:00
New Spanish-Language Consumer Guides Compare Treatments for Depression, Prostate Cancer and Other Conditions

2009-07-28 08:00
Surveyed Oncologists Expect to Prescribe Provenge to about Half of Their Prostate Cancer Patients if the Vaccine is Approved

2009-07-28 08:00
WealthEngine Releases New Prospect Research Tool for Nonprofits

2009-07-27 08:00
Driven by Launch of Emerging Therapies, Overall Prostate Cancer Drug Market Will Increase by $2 Billion Through 2018

2009-07-21 20:00
Elbit Imaging Ltd. Announces Filing of Shelf Prospectus in Israel

2009-07-21 08:00
Orthocare Innovations Receives Prestigious R&D 100 Award for Computerized Prosthesis Alignment System

2009-07-21 08:00
WealthEngine Releases New High Net Worth Prospecting Tool

2009-07-21 04:01
Innovative and Affordable Products Uplift Prospects for Point-of-Use Water Treatment Systems Market in India, Finds Frost & Sullivan

2009-07-20 16:00
Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study

2009-07-17 12:00
Innovative Prostate Cancer Treatment Known as Sonablate(R) HIFU Now Available at Third Site in India

2009-07-14 12:00
ImmunoVaccine Technologies Licenses Immunotope's Breast, Ovarian and Prostate Cancer Antigens

2009-07-10 16:00
BRF - Brasil Foods S.A. Announces it has Filed a Registration Statement and Prospectus with the SEC

2009-07-08 08:00
Banc of America Securities-Merrill Lynch Research Hikes 2010 Global GDP Forecast to 3.7 Percent on Brighter Growth Prospects in the U.S. and China

2009-07-07 12:00
New Report Just Published: World Prostate Cancer Therapeutics Market Report

2009-07-07 08:00
Mylan Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex(R)

2009-07-06 16:00
Formula Announces Filing of Draft Prospectus in Israel

2009-07-01 12:00
New Review on PROSTVAC(TM) Published by Key Investigators From NCI

2009-06-24 08:02
ProStor Systems Sees Strong Market Adoption for ProStor InfiniVault - Announces General Availability of Release 2.0

2009-06-24 08:00
OncoGenex Pharmaceuticals Completes Amendment to Phase 3 Special Protocol Assessment for Confirming Survival Benefit in Patients Receiving OGX-011 with First-Line Docetaxel for Metastatic Prostate Cancer

2009-06-23 16:02
Video: Could U.S. IT Pros Be Losing a Seat at the Strategic Table?

2009-06-23 16:02
Could U.S. IT Pros Be Losing a Seat at the Strategic Table?

2009-06-23 12:00
Turnaround Pros: Lid on Credit Still Tight

2009-06-19 16:02
Experian Helps BtoB Marketers Identify and Target Small Business Prospects During Virtual Trade Show

2009-06-19 08:00
Photos: Soccer Hall of Famer Marcelo Balboa Encourages Men to 'Team Up Against Prostate Cancer'

2009-06-18 08:00
Spectral announces publication demonstrating Toraymyxin(TM) significantly reduces mortality from sepsis in prospective controlled trial

2009-06-18 08:00
Survey: Despite Recession, Prospective Business School Applicants Secure in Employment; Optimistic About Future

2009-06-17 12:00
Organization Announces End Prostate Cancer Tour

2009-06-17 08:00
Prostate Cancer Patient Receives First RapidArc Radiotherapy Treatment at Major Danish Hospital

2009-06-16 12:03
Prospect, VA Residents to Benefit from Verizon Wireless Network Expansion

2009-06-15 20:00
Consumer Reports 'Best Buy Drug' for Enlarged Prostate Could Save Consumers Nearly $3,000 a Year

2009-06-15 12:00
Kimberly-Clark Teams Up With Sports Legends to Launch 'The Depend Campaign to End Prostate Cancer'

2009-06-15 08:00
AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule

2009-06-10 16:00
Record-Breaking Internet Pharmacy Prosecution Nets Millions for Iowa Law Enforcement

2009-06-10 08:01
MWW Group Launches, M.insight, First Mobile App for PR, Marketing and Advertising Pros

2009-06-10 08:00
AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia

2009-06-09 16:02
Franchisors Embrace FAST(TM) Scholarship Program Incenting Prospective Franchisees with Accelerated Success Program

2009-06-05 12:00
Ludwig Institute of Cancer Research Ltd., Brussels Branch, Issues Statement Concerning Prospect Therapeutics Inc's. GCS-100 Molecule

2009-06-01 20:02
Microsoft Office and Kirtsy to Turn Little Rock Women Into Tech-Savvy Pros

2009-06-01 20:02
Microsoft Office and Kirtsy to Turn Denver Women Into Tech-Savvy Pros

2009-06-01 20:02
Microsoft Office and Kirtsy to Turn Houston Women Into Tech-Savvy Pros

2009-06-01 20:02
Microsoft Office and Kirtsy to Turn Charlotte Women Into Tech-Savvy Pros

2009-06-01 20:02
Microsoft Office and Kirtsy to Turn Salt Lake City Women Into Tech-Savvy Pros

2009-06-01 08:02
New at DAM New York 2009, iPharro Media's Enterprise-Class Video Indexing and Identification Server Provides Broadcast Pros With Unique Video Fingerprinting Technology

2009-06-01 08:00
AEterna Zentaris Presents Data Supporting Evaluation of AEZS-108 in Prostate Cancer at ASCO Meeting

2009-06-01 08:00
PROSTVAC(TM) Data Presented at the ASCO Meeting Demonstrates the Potential for Significant Increases in Life Expectancy in Late-Stage Prostate Cancer


Pharmaceutical Business Review

2009-08-17 12:03
Glancy Binkow & Goldberg Files Lawsuit Against Repros To Recover Investors' Loss
Complaint charges the company with violations of federal security laws

2009-08-14 16:03
Amgen To Discuss Denosumab Data With FDA
Denosumab for treatment of bone loss in breast and prostate cancer patients undergoing hormone ablation

2009-08-14 08:03
OncoGenex Reports First Patient Dosing In Phase1 Clinical Trial Of OGX-427
OGX-427, systemic treatment of solid tumors including prostate, non-small cell lung, breast, ovarian, and bladder cancers

2009-08-13 04:02
Repros Reports Class Action Lawsuit Filed Against The Company
Complaint alleges defendants issued materially false and misleading press releases regarding the results of clinical trials for drug Proellex

2009-08-10 04:02
Murray, Frank & Sailer Files Class Action Lawsuit Against Repros Therapeutics
Alleges that defendants issued materially false and misleading press releases regarding the success of clinical trials for Proellex

2009-08-07 12:04
FDA Puts Repros' Proellex On Clinical Hold
Decision was based on the occurrence of increased liver enzymes with 50mg and 25mg doses of Proellex

2009-08-07 04:04
Bellicum Initiates Phase I/II Clinical Trial Of BP-GMAX-CD1
BP-GMAX-CD1, for the treatment of prostate cancer

2009-08-06 12:03
ProStrakan Submits New Drug Application For Abstral To FDA
Abstral, for the treatment of breakthrough cancer pain in opioid-tolerant patients

2009-08-05 12:03
EpiCept Files New Drug Submission For Approval Of Ceplene In Canada
Company in continuing talks with prospective partners for European marketing rights

2009-08-04 04:03
Repros Therapeutics Suspends Dosing Of Proellex
Suspension of dosing would involve all ongoing clinical trials with Proellex

2009-07-30 12:03
Recordati Signs License Agreement With Pharmaplan
Silodosin, a new compound indicated for the treatment of signs and symptoms of benign prostatic hyperplasia

2009-07-24 04:03
Repros Therapeutics Provides Update On Proellex Clinical Program
Company to go forward with 25mg and 12.5mg doses

2009-07-22 12:04
Takeda, Sucampo Report Results For Two Phase 3 Trials
Lubiprostone, for treatment of opioid-induced bowel dysfunction in patients with chronic, non-cancer pain

2009-07-21 12:05
Pro-Pharmaceuticals Prevails In Trade Secret Lawsuit
Prospect Therapeutics purchased certain assets from the GlycoGenesys bankruptcy estate, and continued prosecuting the claims against the company and Dr. Platt

2009-07-20 04:04
Ambrilia, Kotinos Sign Agreement For Sale Of PCK3145
To develop a therapy with potential to address unmet medical need in advanced metastatic prostate cancer

2009-07-08 12:03
Repros Amends License Agreement With NIH
Amendment has revised the dates by which development and commercialization benchmarks must be met

2009-07-08 04:03
Mylan Receives FDA Approval For Bicalutamide
Bicalutamide, a generic version of AstraZeneca's prostate cancer treatment Casodex

2009-07-08 04:03
GTx Initiates Phase I Prostate Cancer Trial
To establish proof of the ability of GTx-758 to reduce testosterone

2009-07-03 04:04
Repros Therapeutics Provides Update For Proellex Clinical Program
Proellex for the treatment of dysmenorrhea, non-menstrual pelvic pain and dyspareunia

2009-06-25 04:03
Actavis Launches Finasteride As Patent Expires In France
Finasteride, used for the treatment of prostate cancer, is generic equivalent of Merck?s Proscar

2009-06-23 04:03
Mayo Clinic Reports Data On Prostate Cancer Study With Ipilimumab
Ipilimumab, a fully human antibody that binds to CTLA-4

2009-06-17 12:04
Molecular Insight Declares Clinical Data On Prostate Cancer Trial
Trofex to treat and detect metastatic prostate cancer

2009-06-11 12:04
AEterna Zentaris Initiates Extended Study For Benign Prostatic Hyperplasia
Study to be followed-up for safety, international prostate symptom score and quality of life

2009-06-08 12:03
Active Biotech Initiates Phase-II Clinical Trial For Prostate Cancer Drug
The study encompasses symptom free patients with metastatic, hormone-resistant, prostate cancer.

2009-06-03 12:03
EDAP Signs Distribution Agreements In Argentina, Brazil And Chile
EDAP TMS S.A. (EDAP), a developer and marketer of Ablatherm, has signed distribution agreements with partners in Argentina, Brazil and Chile to drive adoption of Ablatherm in the region as a therapeutic option for patients with prostate cancer. The company's partners will include Jorge Litter in Argentina, H. Strattner in Brazil and UMS in Chile.

2009-06-03 12:03
Medivation' Phase 1-2 Trial Of MDV3100 For Prostate Cancer Patients Yield Positive Results
MDV3100 demonstrated anti-tumor activity in both chemotherapy-naive and post-chemotherapy CRPC patients

2009-06-03 12:03
Optos CFO Allan Watson Plans To Step Down
Optos plc (Optos), a retinal imaging company, said that Allan Watson has informed the board that he intends to step down from his role as chief financial officer (CFO) and leave the company in due course. Allan is to join ProStrakan Group plc as CFO.


Forbes.com

2009-07-20 00:02
Lupus Drug Revives Human Genome Sciences' Prospects
Benlysta is first new medicine to succeed against disease in 50 years.